Ian Gourley
Director Técnico/Científico/I+D en IMMUNOVANT, INC. .
Cargos activos de Ian Gourley
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IMMUNOVANT, INC. | Director Técnico/Científico/I+D | - | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Historial de carrera de Ian Gourley
Antiguos cargos conocidos de Ian Gourley.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - | - |
Formación de Ian Gourley.
| Queen's University of Belfast | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 3 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Empresas privadas | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Ian Gourley
- Experiencia